Cognito Therapeutics vs Grey Matter Neurosciences
Cognito Therapeutics vs Grey Matter Neurosciences, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cognito Therapeutics is on 50/100 and Grey Matter Neurosciences on 40/100.
Where each one leads
Cognito Therapeutics
- our overall score: 50/100 against 40/100
- funding raised: $213M against $14.0M
Grey Matter Neurosciences
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Cognito Therapeutics | Grey Matter Neurosciences |
|---|---|---|
| What it is | Developing a novel therapeutic approach for Alzheimer's disease. | Developing non-invasive ultrasound technology to treat age-related brain diseases like Alzheimer's. |
| Category | Biotechnology, Medical Devices, Neuroscience, Healthcare | Neurotechnology, Medical Devices, HealthTech, Biotechnology |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Hardware |
| Founded | 2011 | 2021 |
| Headquarters | Boston, USA | Toronto, Canada |
| Status | Active | Active |
Size, funding and growth
| Measure | Cognito Therapeutics | Grey Matter Neurosciences |
|---|---|---|
| Total funding | $213M | $14.0M |
| Latest round | Series C | Seed |
| Valuation | $487M | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cognito Therapeutics | Grey Matter Neurosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 50/100 | 40/100 |
| Traction | 40/100 | 36/100 |
| Team | 60/100 | 30/100 |
| Community | Not published | 15/100 |
| Search visibility | 10/100 | 12/100 |
| Quality | 65/100 | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | Not published |
| Domain ratingLink authority, 0-100 | 47/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cognito Therapeutics | Grey Matter Neurosciences |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Open source | Yes | No |
Cognito Therapeutics vs Grey Matter Neurosciences: common questions
Which is better, Cognito Therapeutics or Grey Matter Neurosciences?
On our 0-100 score Cognito Therapeutics rates higher (50/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Cognito Therapeutics and Grey Matter Neurosciences compare on the numbers?
Cognito Therapeutics leads on our overall score (50/100 against 40/100), funding raised ($213M against $14.0M).
Read the full Cognito Therapeutics review and pricing or the Grey Matter Neurosciences review and pricing. You can also browse other Cognito Therapeutics alternatives we track.